Can a child's background shape their ICU journey? a new study asks

NCT ID NCT07771179

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 18, 2026 · Last updated Aug 19, 2026 · Updated 1 time

Summary

This study looks at how factors like ethnicity, deprivation, language, and healthcare access affect outcomes for children admitted to paediatric intensive care. Researchers will interview parents and healthcare professionals to understand experiences and barriers, and also analyse existing NHS data to see if certain groups face higher risks. The goal is to identify points in a child's healthcare journey where earlier support could make a difference.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Semi-structured interviews with parents/carers and healthcare professionals, plus analysis of existing NHS data
What this could lead to
If successful, this could point to where earlier support or intervention might reduce inequalities in children's intensive care outcomes.
What could go wrong
This is a small, early-stage qualitative study with only 40 participants, so findings may not apply broadly. Interviews rely on personal experiences, which can vary widely.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Apr 2027

An estimate. Start dates often move.

Expected to finish

Jul 2031

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

1. Parents and carers of children admitted to PICU at GOSH, Birmingham Children's Hospital, St Mary's Hospital, or Royal Manchester Children's Hospital. 2. Health care professionals working in PICU or referring patients into PICU recruited from GOSH, Birmingham Children's Hospital, St Mary's Hospital, or Royal Manchester Children's Hospital.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Parents/Carers Inclusion Criteria: * Parent or carer of a child admitted to paediatric intensive care at one of the participating sites: Great Ormond Street Hospital, Birmingham Children's Hospital, St Mary's Hospital, or Royal Manchester Children's Hospital. * Aged 18 years or over. * Able to provide informed consent. * Approached no earlier than 48 hours after the child's admission to PICU. * Where the child has died, parents/carers will be approached between 6 and 12 weeks following the death. * Parents/carers who do not speak English may be included, with interviews conducted using a professional interpreter where required. Exclusion Criteria: * Individuals unable to provide informed consent. * Families of children with ongoing safeguarding concerns at the time of potential recruitment. * Families who are actively involved in a formal complaint process against the hospital at the time of recruitment. * Parents/carers approached within 48 hours of PICU admission. * Bereaved parents/carers approached outside the 6-12 week bereavement window. Healthcare professionals Inclusion Criteria: * Healthcare professionals aged 18 years or over who either: * work in a paediatric intensive care unit, or * are involved in referring children to paediatric intensive care, at one of the four participating sites. * Able to provide informed consent. Exclusion Criteria: \- Individuals unable to provide informed consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Paediatric intensive care are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Racism

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.